ask="4.75"
ask_size="1100"
average_daily_volume="209768"
bid="4.19"
bid_size="8800"
book_value="0.74"
change="-0.09"
change_from_200_day_moving_average="1.43"
change_from_50_day_moving_average="1.06"
change_from_52_week_high="-0.46"
change_From_52_week_low="2.82"
change_in_percent="-2.05%"
close="4.29"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.11"
ebitda="-30.33M"
eps_estimate_current_year="-1.14"
eps_estimate_next_quarter="-0.23"
eps_estimate_next_year="-0.96"
ex_dividend_date="N/A"
float_shares="19694000"
high="4.45"
high_52_weeks="4.75"
last_trade_date="3/2/2017"
last_trade_price="4.29"
last_trade_size="986"
last_trade_time="4:00pm"
low="4.19"
low_52_weeks="1.47"
market_capitalization="146.49M"
moving_average_200_day="2.86"
moving_average_50_day="3.23"
name="Fate Therapeutics
Inc."
notes="N/A"
one_year_target_price="5.83"
open="4.45"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+49.89%"
percent_change_from_50_day_moving_average="+33.01%"
percent_change_from_52_week_high="-9.68%"
percent_change_from_52_week_low="+191.84%"
previous_close="4.38"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.90"
price_per_sales="33.60"
revenue="4.45M"
shares_outstanding="34148000"
short_ratio="3.19"
stock_exchange="NGM"
symbol="FATE"
volume="244000"
weeks_range_52="1.47 - 4.75"
